Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
2026-07-30

Regulatory Watch

AI-synthesized intelligence from CBN, FIRS, CAC, NAFDAC, SON, and NEPZA — so your business stays ahead of regulatory change.

July 30, 2026 7 updates 2 sources
NAFDAC is intensifying enforcement against counterfeit and substandard medical products, including a ban on sub-200ml alcohol sachets and blacklisting of violators. SON is digitizing trade facilitation, while NEPC provides export guidance for fish farms. Nigerian SMBs in pharma, food, and export sectors must tighten compliance and supply chain integrity.
What's being regulated
Pharmaceuticals Medical Devices Alcohol Beverages Food Export International Trade
Latest regulatory changes
Handling Manufacturer Investigation Reports for Medical Devices and IVDs
NAFDAC
NAFDAC issues guidance on Manufacturer Investigation Reports (MIRs) for medical devices and IVDs to assess complaints and adverse events.
SMBs in medical device importation or manufacturing must implement MIR procedures to ensure patient safety and regulatory compliance.
NAFDAC Continued Enforcement of the Ban on Sub-200ml Sachet & PET Bottle Alcoholic Products: Update on Nationwide Mop-Up Operation.
NAFDAC
NAFDAC continues nationwide mop-up of sub-200ml sachet and PET bottle alcoholic products, enforcing the federal ban.
Alcohol beverage SMBs must cease production and distribution of these packages to avoid seizure and penalties.
Blacklisting of Onifam Laboratories Ltd
NAFDAC
NAFDAC blacklists Onifam Laboratories Ltd for regulatory misrepresentation and improper use of approvals.
SMBs in pharma must ensure transparent dealings with NAFDAC to avoid blacklisting and business disruption.
Public Alert No. 037/2026 – Alert on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension
NAFDAC
NAFDAC alerts public to suspected counterfeit Pulmicort® inhalation suspension in the market.
Pharmacy SMBs and distributors must verify product authenticity and report suspicious batches to NAFDAC.
Public Alert No. 036/2026 – Alert on Suspected Counterfeit Products Mimicking Forxiga® (Dapagliflozin)
NAFDAC
NAFDAC alerts public to suspected counterfeit Forxiga® products infringing AstraZeneca's authorization.
SMBs handling diabetes medications must strengthen supply chain checks to avoid counterfeit stock.
SON rides on e-platform to facilitate international trade
SON
SON adopts e-platform to streamline international trade processes.
Exporting SMBs can benefit from faster SON certifications and reduced paperwork via digital platform.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
NEPC
NEPC provides guide for fish farm registration to facilitate exports.
Fish farming SMBs can access export markets by following NEPC registration process.
What this means for your business
Increased NAFDAC enforcement against counterfeit drugs and banned alcohol packages
Digitalization of SON trade facilitation reduces export barriers
NEPC support for fish farm exports opens new market opportunities
Blacklisting risk for pharma SMBs with non-compliant practices
What to do next
1 Review and update MIR procedures for medical device SMBs
2 Cease production/sale of sub-200ml alcohol sachets and PET bottles
3 Verify authenticity of all pharmaceutical products in stock
4 Register with NEPC for fish farm export compliance
5 Utilize SON e-platform for faster certification
← Previous edition
Browse archive
Next edition →

Never miss a regulatory change

From CBN monetary policy to FIRS tax circulars — our AI Workspace monitors the regulatory landscape so you don't have to.

Create free account